ArticleJACC. CardioOncology2023

Ibrutinib Is Associated With Increased Cardiovascular Events and Major Bleeding in Older CLL Patients.

Akiva Diamond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.